BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23963546)

  • 1. Valsartan/amlodipine compared to nifedipine GITS in patients with hypertension inadequately controlled by monotherapy.
    Wang JG; Zeng WF; He YS; Chen LL; Wei M; Li ZP; Zhang BW; Li Y;
    Adv Ther; 2013 Aug; 30(8):771-83. PubMed ID: 23963546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved blood pressure control with nifedipine GITS/valsartan combination versus high-dose valsartan monotherapy in mild-to-moderate hypertensive patients from Asia: results from the ADVISE study, a randomized trial.
    Ke YN; Dong YG; Ma SP; Yuan H; Ihm SH; Baek SH;
    Cardiovasc Ther; 2012 Dec; 30(6):326-32. PubMed ID: 23134522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of a single-pill combination of amlodipine/valsartan in Asian hypertensive patients inadequately controlled with amlodipine monotherapy.
    Ke Y; Zhu D; Hong H; Zhu J; Wang R; Cardenas P; Zhang Y
    Curr Med Res Opin; 2010 Jul; 26(7):1705-13. PubMed ID: 20469975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial comparing the effects of a low-dose combination of nifedipine GITS and valsartan versus high-dose monotherapy on central hemodynamics in patients with inadequately controlled hypertension: FOCUS study.
    Park JB; Ha JW; Jung HO; Rhee MY;
    Blood Press Monit; 2014 Oct; 19(5):294-301. PubMed ID: 24915052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
    Assaad-Khalil SH; Najem R; Sison J; Kitchlew AR; Cho B; Ueng KC; DiTommaso S; Shete A
    Vasc Health Risk Manag; 2015; 11():71-8. PubMed ID: 25653536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-life effectiveness, safety, and tolerability of amlodipine/valsartan or amlodipine/valsartan/hydrochlorothiazide single-pill combination in patients with hypertension from Pakistan.
    Khan W; Moin N; Iktidar S; Sakrani J; Abid R; Afzal J; Maheshwary N; Kumar K; Siddiqi A; Qadir M
    Ther Adv Cardiovasc Dis; 2014 Apr; 8(2):45-55. PubMed ID: 24562476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of the Up-titration of Nifedipine GITS and Valsartan or Low-dose Combination in Uncontrolled Hypertension: the FOCUS Study.
    Park JB; Shin JH; Kim DS; Youn HJ; Park SW; Shim WJ; Park CG; Kim DW; Lee HY; Choi DJ; Rim SJ; Lee SY; Kim JH;
    Clin Ther; 2016 Apr; 38(4):832-42. PubMed ID: 26996246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of long-acting nifedipine GITS/OROS monotherapy or combination therapy in hypertensive patients: results of a 12-week international, prospective, multicentre, observational study.
    Ueng KC; Ningling S; El Maksod A; Hung KY; Yuehui Y
    Clin Drug Investig; 2011; 31(9):631-42. PubMed ID: 21591818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amlodipine/valsartan 5/160 mg versus valsartan 160 mg in Chinese hypertensives.
    Zhu D; Yang K; Sun N; Gao P; Wang R; Grosso A; Zhang Y;
    Int J Cardiol; 2013 Sep; 167(5):2024-30. PubMed ID: 22647413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on valsartan monotherapy.
    Sinkiewicz W; Glazer RD; Kavoliuniene A; Miglinas M; Prak H; Wernsing M; Yen J
    Curr Med Res Opin; 2009 Feb; 25(2):315-24. PubMed ID: 19192976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amlodipine/valsartan single-pill combination: a prospective, observational evaluation of the real-life safety and effectiveness in the routine treatment of hypertension.
    Karpov Y; Dongre N; Vigdorchik A; Sastravaha K
    Adv Ther; 2012 Feb; 29(2):134-47. PubMed ID: 22271158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of sacubitril/valsartan (LCZ696) add-on to amlodipine in Asian patients with systolic hypertension uncontrolled with amlodipine monotherapy.
    Wang JG; Yukisada K; Sibulo A; Hafeez K; Jia Y; Zhang J
    J Hypertens; 2017 Apr; 35(4):877-885. PubMed ID: 28030431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized multicenter study on ambulatory blood pressure and arterial stiffness in patients treated with valsartan/amlodipine or nifedipine GITS.
    Xu SK; Huang QF; Zeng WF; Sheng CS; Li Y; Wang JG
    J Clin Hypertens (Greenwich); 2019 Feb; 21(2):252-261. PubMed ID: 30582271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of ambulatory blood pressure monitoring compared with clinic and home blood pressure measures in evaluating moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy.
    Giles TD; Oparil S; Ofili EO; Pitt B; Purkayastha D; Hilkert R; Samuel R; Sowers JR
    Blood Press Monit; 2011 Apr; 16(2):87-95. PubMed ID: 21386706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of the antihypertensive efficacy of amlodipine and nifedipine GITS after two 'missed doses': a randomised, double-blind comparative trial in Asian patients.
    Ongtengco I; Morales D; Sanderson J; Lu ZR; Beilin LJ; Burke V; Puddey IB; Tanomsup S; Dayi H; Rahardjo P; Zambahari DR; Chen CY; Soenarta AA; Buranakitjaroen P; Tan C; Soon TK; Wu DJ
    J Hum Hypertens; 2002 Nov; 16(11):805-13. PubMed ID: 12444542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the valsartan/amlodipine combination and nifedipine gastrointestinal therapeutic system monotherapy on brachial pulse pressure and radial augmentation index in hypertensive patients.
    Xu SK; Zeng WF; Li Y; Chen LL; Xie JH; Wang JG
    Blood Press Monit; 2021 Aug; 26(4):251-256. PubMed ID: 33734121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
    Frampton JE; Scott LJ
    Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.